TickerFactsScreenerDevelopers

BioXcel Therapeutics, Inc. (BTAI) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$2.20M2018: -$13.51M2019: -$27.10M2020: -$66.35M2021: -$82.15M2022: -$135.34M2023: -$155.01M2024: -$72.03M2025: -$57.62M-$57.62M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$57.62M+20.0%
2024-$72.03M+53.5%
2023-$155.01M-14.5%
2022-$135.34M-64.7%
2021-$82.15M-23.8%
2020-$66.35M-144.8%
2019-$27.10M-100.6%
2018-$13.51M-515.2%
2017-$2.20M—